The Biovista Vizit newly implemented Drug Combination Detection feature is a milestone unlocking drug-drug interactions reliable statistics and safety signal detection.
Author: Vassilis Virvilis
NEWROAD final meeting
On April 24th, Biovista was happy to participate at the NEWROAD final meeting (www.new-road.eu), hosted by the University of Salerno. At the end of this successful project we are pleased to confirm that our original vision, in view of developments in the healthcare field and the impact of AI on scientific R&D, is today more … Read More
Biovista Vizit New Corpus: ClinicalTrials.gov
By V. Virvilis and E. Lekka The latest release of Biovista Vizit (September 2025) features the integration of the ClinicalTrials.gov database. This is the fourth public corpus integration of Biovista Vizit alongside MEDLINE following HPO, AOP and PDB. This integration makes a significant effort to address the irregular and non-standardized manner in which data are … Read More
Biovista Vizit New Corpus: HPO
By V. Virvilis and E. Lekka The latest release of Biovista Vizit (March 2025) brings the integration of Human Phenotype Ontology (HPO) annotations into the Vizit Knowledge Graph. This is the 3rd corpus integration alongside with MEDLINE after AOP and PDB. The integration allows for additional links and evidence from HPO, with higher priority since … Read More
Biovista Vizit January 2025 Release – AOP Features
By V. Virvilis and E. Lekka The latest release of Biovista Vizit (January 2025) brings a few precious features especially relevant to our AOP users. The full changelog is also available. Note that Biovista Vizit is a free official 3rd party tool listed in the AOP-Wiki. The highlight of this release is the separation of … Read More